Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Rankning i aktier #340
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Aktiekurs
$48.86
Marknadsvärde
$72.62B
Förändring (1 dag)
1.69%
Förändring (1 år)
-54.20%
Land
US
Handel Boston Scientific Corporation (BSX)

Kategori

P/E-tal för Boston Scientific Corporation (BSX)
P/E-tal per September 2026 TTM: 19.48
Enligt Boston Scientific Corporation senaste finansiella rapporter och aktiekurs är det aktuella P/E-talet (TTM) 19.48. I slutet av 2024 hade företaget ett P/E-tal på 70.89.
Historik för P/E-tal för Boston Scientific Corporation från 2000 till 2026
P/E-tal vid slutet av varje år
År P/E-tal Ändra
2026 (TTM) 19.48 -60.18%
2025 48.91 -31.01%
2024 70.89 34.45%
2023 52.73 -44.39%
2022 94.83 63.23%
2021 58.10 -109.35%
2020 -621.10 -4,739.24%
2019 13.39 -54.16%
2018 29.21 -91.06%
2017 326.58 285.92%
2016 84.63 -182.61%
2015 -102.44 -30.52%
2014 -147.45 10.67%
2013 -133.23 6,624.20%
2012 -1.98 -110.84%
2011 18.28 -269.40%
2010 -10.79 -18.52%
2009 -13.24 132.42%
2008 -5.70 -83.69%
2007 -34.93 471.06%
2006 -6.12 -118.98%
2005 32.22 15.12%
2004 27.99 -56.60%
2003 64.49 39.54%
2002 46.22 -124.91%
2001 -185.54 -1,347.09%
2000 14.88 0.00%
P/E-tal för liknande företag eller konkurrenter
Företag P/E-tal Skillnad i P/E-tal Land
35.48 82.19%
US
33.28 70.87%
US
21.39 9.82%
IE
52.16 167.79%
US
- -
DE
Hur man läser ett P/E-tal

P/E-talet (Price/Earnings) mäter förhållandet mellan ett företags aktiekurs och dess vinst per aktie.
Ett lågt men positivt P/E visar ett företag med hög vinst i förhållande till värderingen och kan vara undervärderat. Ett högt negativt (nära 0) P/E indikerar stora förluster.

Företag med P/E över 30 eller negativt ses ofta som "tillväxtaktier", vilket innebär att investerare förväntar sig tillväxt eller framtida lönsamhet.

Företag med positivt P/E under 10 ses som "värdeaktier" och är redan lönsamma men med begränsad tillväxtpotential.